Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.

NCT: NCT05113927 · COMPLETED

NCT IDNCT05113927
StatusCOMPLETED
Start Date2021-12-01
Completion2024-10-21
SponsorPerimeter Medical Imaging (INDUSTRY)
First posted
Last updated

Brief Summary

This is a multi-center, randomized, two-arm study designed to measure the effectiveness of the SELENE system in reducing the number of unaddressed positive margins in breast lumpectomy procedures when used in addition to standard intraoperative margin assessment.

Frequently Asked Questions

What is Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.?

Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery. is a clinical trial registered under NCT05113927. Current status: COMPLETED.

What is the status of NCT05113927?

The current status of NCT05113927 (Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery.) is: COMPLETED.

When did Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery. start?

Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery. started on 2021-12-01.

Related Devices

K160240Perimeter Otis™ 1.0 Optical Coherence Tomography SystemPerimeter Medical Imaging, Inc. K171560OTIS Optical Coherence Tomography SystemPerimeter Medical Imaging, Inc. K190404OTIS Optical Coherence Tomography SYstemPerimeter Medical Imaging, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑